Oxcarbazepine in youths with autistic disorder and significant disruptive behaviors [10]

American Journal of Psychiatry

Volumn 164, Issue 5, 2007, Pages 832-833

  Kapetanovic, Suad ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

OLANZAPINE; OXCARBAZEPINE; RISPERIDONE;

ADOLESCENT; ADULT; AMINOTRANSFERASE BLOOD LEVEL; ANGER; ATTENTION; AUTISM; CASE REPORT; COMPULSION; COOPERATION; DISRUPTIVE BEHAVIOR; DOSE RESPONSE; DRUG DOSE TITRATION; DRUG RESPONSE; DRUG WITHDRAWAL; FEMALE; HUMAN; LETTER; MALE; PATIENT COMPLIANCE; PRESCHOOL CHILD; PRIORITY JOURNAL; SIDE EFFECT; SLEEP PATTERN; TREATMENT FAILURE; TREATMENT RESPONSE; WEIGHT GAIN;

EID: 34249311977     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/ajp.2007.164.5.832     Document Type: Letter

References (3)

1. Volkmar F, Cook EH Jr, Pomeroy J, Realmuto G, Tanguay P: Practice parameters for the assessment and treatment of children, adolescents, and adults with autism and other pervasive developmental disorders. J Am Acad Child Adolesc Psychiatry 1999; 38(suppl 12):32S-54S
2. Kapetanovic S, Simpson GM: Review of antipsychotics in children and adolescents. Expert Opin Pharmacother 2006; 7:1871-1885
3. King BH, Bostic JQ: An update on pharmacologic treatments for autism spectrum disorders. Child Adolesc Psychiatr Clin N Am 2006; 15:161-175